Accessibility settings

This paper is in the following e-collection/theme issue:

Viewpoint (4) New Methods (1194) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (232) Artificial Intelligence (2423) Precision Medicine (194) Computational modeling of biological processes (14) Bioinformatics, genomics, tools and databases (38) Drug discovery and development (12) Theme Issue: AI and ChatGPT in Dermatology (25)

Published on in Vol 6 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/69800, first published .
Harnessing AI and Quantum Computing for Revolutionizing Drug Discovery and Approval Processes: Case Example for Collagen Toxicity

Harnessing AI and Quantum Computing for Revolutionizing Drug Discovery and Approval Processes: Case Example for Collagen Toxicity

Harnessing AI and Quantum Computing for Revolutionizing Drug Discovery and Approval Processes: Case Example for Collagen Toxicity

Authors of this article:

David Melvin Braga1 Author Orcid Image ;   Bharat Rawal2 Author Orcid Image
Article Authors Cited by (3) Tweetations Metrics

Journals

  1. Das U. Transforming Precision Medicine through Generative AI: Advanced Architectures and Tailored Therapeutic Design for Patient‐Specific Drug Discovery. ChemistrySelect 2025;10(36) View
  2. Matarèse B. Quantum and Artificial Intelligence in Drugs and Pharmaceutics. BioChem 2026;6(1):2 View
  3. Sargolzaei M, Nikoofard H. AI-driven quantum chemical exploration of multi-target synthetic opioid analogs for enhanced therapeutic profiles. Journal of Computer-Aided Molecular Design 2026;40(1) View